Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers.

By Aldea, M. | Cuezva, J.M. | Sánchez Aragó, María. Oncogenesis, 2013 . 2:e46. , Formato Vancouver: Sánchez-Aragó M, Formentini L, Martínez-Reyes I, García-Bermudez J, Santacatterina F, Sánchez-Cenizo L et al. Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers. Oncogenesis. 2013 Apr 22;2:e46.

Place Hold on Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers.

Reverse phase protein microarrays quantify and validate the bioenergetic signature as biomarker in colorectal cancer

By Aldea, M. | Cuezva, J.M. | Núñez de Arenas, Cristina. Cancer Letters, 2011 . 311(2):210-218. , Formato Vancouver: Aldea M, Clofent J, Núñez de Arenas C, Chamorro M, Velasco M, Berrendero JR, et al. Reverse phase protein microarrays quantify and validate the bioenergetic signature as biomarker in colorectal cancer. Cancer Lett. 2011;311(2):210-8.

Place Hold on Reverse phase protein microarrays quantify and validate the bioenergetic signature as biomarker in colorectal cancer

Search for 'an:"1891" and au:Aldea, M.'

Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers.

Reverse phase protein microarrays quantify and validate the bioenergetic signature as biomarker in colorectal cancer